Next our in vitro studies uncovered that COX-2/PGE2 regulated CRC cell migration/invasion process through JAK2/STAT3 signaling, and over-expression of COX-2 and PGE2 reversed the inhibitory action of berberin on JAK2/STAT3 activation and cancer cell mobility. The gene discussed is JAK2; the disease is colorectal carcinoma.